Pancreatic Cancer Research

ResearcherCross Cancer InstituteActive in the last 2 years

Karen E. Mulder

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6832-0081; OpenAlex author ID A5014350537. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use. Co-author DOI 10.3390/curroncol32030128↗
  2. Looking to the future: biomarkers in the management of pancreatic adenocarcinoma. First author DOI 10.3390/ijms12095895↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akmal Ghafoor · 1 shared paper, 2025 · strength 0.25
  2. Rachel Anne Goodwin · 1 shared paper, 2025 · strength 0.25
  3. Petr Kavan · 1 shared paper, 2025 · strength 0.25
  4. Joanna Gotfrit · 1 shared paper, 2025 · strength 0.25
  5. Shahid Ahmed · 1 shared paper, 2025 · strength 0.25
  6. Jennifer L. Spratlin · 1 shared paper, 2011 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.